The role of serum albumin in the metabolism of Boc5: Molecular identification, species differences and contribution to plasma metabolism
Ge, Guang-Bo1; Ai, Chun-Zhi1; Hu, Wen-Bing2; Hou, Jie3; Zhu, Liang-Liang1; He, Gui-Yuan1; Fang, Zhong-Ze1; Liang, Si-Cheng1; Wang, Fu-Yi2; Yang, Ling1
刊名european journal of pharmaceutical sciences
2013-01-23
卷号48期号:1-2页码:360-369
关键词Boc5 Albumin Pseudo-esterase Transesterification Species differences
通讯作者汪福意 ; 杨凌
产权排序待补充
合作状况
英文摘要boc5, the first nonpeptidic agonist of glucagon-like peptide-1 receptor, has been recognized as a potential candidate for treatment of diabetes. however, the metabolic behaviors of this novel molecule in both human and experimental animals remain unclear. this study aimed to explore the metabolic behaviors of boc5 in biological preparations from human, pig and rat. boc5 was found to be very stable in liver microsomes of human, pig and rat, but it can be degraded to two metabolites in plasma from all three species, via the successive hydrolysis of the c-22 esters. chemical inhibition studies using selective esterase inhibitors and assays with purified enzymes suggested that boc5 hydrolysis in human was totally mediated by human serum albumin (hsa) rather than esterases. esi-tof-ms/ms analysis revealed that lys525 of hsa could be modified by treatment with boc5, strongly suggesting the pseudo-esterase activity of albumin. studies on species differences in this albumin-mediated metabolism showed large species differences in degradation rate of boc5, the half lives of boc5 in plasma from three various species varied from 23.5 h to 83.1 h, but they were much closer to the half lives of boc5 in corresponding serum albumins, implying the predominant role of serum albumin in plasma metabolism of boc5. additionally, the effects of various ligands including fatty acids and several drugs with unambiguous binding sites on hsa, on the pseudo-esterase activity of hsa, were also investigated using both experimental and molecular modelling studies. these results showed that the binding of various ligands to hsa could significantly affect the pseudo-esterase activity of hsa towards boc5, due to the ligand-induced conformation changes of hsa. (c) 2012 elsevier b.v. all rights reserved.
学科主题物理化学
WOS标题词science & technology ; life sciences & biomedicine
类目[WOS]pharmacology & pharmacy
研究领域[WOS]pharmacology & pharmacy
关键词[WOS]glucagon-like peptide-1 ; esterase-like activity ; free fatty-acids ; type-2 diabetes-mellitus ; receptor agonist ; substituted aspirins ; crystal-structures ; glycemic control ; drug discovery ; beta-cell
收录类别SCI
资助信息1,1
原文出处369
语种英语
WOS记录号WOS:000315613500040
公开日期2014-09-11
内容类型期刊论文
源URL[http://159.226.238.44/handle/321008/119127]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Peoples R China
2.Chinese Acad Sci, Inst Chem, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China
3.Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China
推荐引用方式
GB/T 7714
Ge, Guang-Bo,Ai, Chun-Zhi,Hu, Wen-Bing,et al. The role of serum albumin in the metabolism of Boc5: Molecular identification, species differences and contribution to plasma metabolism[J]. european journal of pharmaceutical sciences,2013,48(1-2):360-369.
APA Ge, Guang-Bo.,Ai, Chun-Zhi.,Hu, Wen-Bing.,Hou, Jie.,Zhu, Liang-Liang.,...&Yang, Ling.(2013).The role of serum albumin in the metabolism of Boc5: Molecular identification, species differences and contribution to plasma metabolism.european journal of pharmaceutical sciences,48(1-2),360-369.
MLA Ge, Guang-Bo,et al."The role of serum albumin in the metabolism of Boc5: Molecular identification, species differences and contribution to plasma metabolism".european journal of pharmaceutical sciences 48.1-2(2013):360-369.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace